Get API access

Wall Street analysts upgrade Summit Therapeutics to Buy rating

2 statements on Sep 28, 2026 22:27 UTC
Part of Companies & earnings
NewsAnalysis
Created
Updated
ASTRAZENECASUMMIT THERAPEUTICSSUMT
All topics

Statements (2)

  1. Bullish

    Summit Therapeutics stock surged following AstraZeneca's announcement of a $2 billion investment

    barrons.comHigh importance
  2. Bullish

    Summit Therapeutics shares are likely to surge following AstraZeneca's announcement of a $2 billion investment and collaboration on cancer drug development.

    wsj.com

FinTopic

AI-powered financial news intelligence platform with interactive visualizations

Features

  • Interactive Treemap View
  • Real-time Sentiment Analysis
  • Multi-source Aggregation
  • Advanced Filtering

Product

Data

  • Real-time updates (within minutes)
  • Live sentiment analysis
  • Multi-source aggregation

© FinTopic. Market intelligence for modern traders.